| Literature DB >> 32899462 |
Konrad Kamil Hus1, Łukasz Marczak2, Vladimír Petrilla3,4, Monika Petrillová5, Jaroslav Legáth1,6, Aleksandra Bocian1.
Abstract
The dynamic development of venomics in recent years has resulted in a significant increase in publicly available proteomic data. The information contained therein is often used for comparisons between different datasets and to draw biological conclusions therefrom. In this article, we aimed to show the possible differences that can arise, in the final results of the proteomic experiment, while using different research workflows. We applied two software solutions (PeptideShaker and MaxQuant) to process data from shotgun LC-MS/MS analysis of Naja ashei venom and collate it with the previous report concerning this species. We were able to provide new information regarding the protein composition of this venom but also present the qualitative and quantitative limitations of currently used proteomic methods. Moreover, we reported a rapid and straightforward technique for the separation of the fraction of proteins from the three-finger toxin family. Our results underline the necessary caution in the interpretation of data based on a comparative analysis of data derived from different studies.Entities:
Keywords: absolute protein quantification; label-free shotgun mass spectrometry; snake venom; venomics
Mesh:
Substances:
Year: 2020 PMID: 32899462 PMCID: PMC7566006 DOI: 10.3390/biom10091282
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1The comparison of the number of proteins identified using different research workflows. Shotgun LC-MS/MS strategy yielded in the identification of 37 and 39 proteins for PeptideShaker (PS) and MaxQuant (MQ) approaches, respectively. Both software provided a relatively high share of workflow-specific proteins. Previous 2DE-MS/MS analysis allowed for the detection of 19 proteins.
Protein families detected in Naja ashei venom using different research workflows. The values in brackets represent the percentage share of a given group in the proteome, determined using workflow-specific quantitative analysis.
| Research Workflow | |||
|---|---|---|---|
| Protein Family | 2DE-MS/MS | Shotgun | Shotgun |
| 3FTx | +(68.98%) | +(59.19%) | +(79.28%) |
| PLA2 | +(27.06%) | +(32.32%) | +(18.86%) |
| SVMP | +(2.13%) | +(2.26%) | +(0.43%) |
| VNGF | +(1.00%) | +(2.18%) | +(0.81%) |
| CRISP | +(0.70%) | +(1.43%) | +(0.26%) |
| CVF | +(0.12%) | +(0.14%) | +(0.02%) |
| Nucleases | +(0.01%) | +(1.55%) | +(0.10%) |
| Ig-like | - | +(0.31%) | +(0.08%) |
| GPx | - | +(0.31%) | +(0.05%) |
| LAAO | - | +(0.21%) | +(0.02%) |
| PDE | - | +(0.11%) | +(0.01%) |
| KUN | - | - | +(0.09%) |
| PLB | - | - | +(<0.01%) |
3FTx (Three-finger toxin); PLA2 (Phospholipase A2); SVMP (Snake venom metalloproteinase); VNGF (Venom nerve growth factor); CRISP (Cysteine-rich secretory protein); CVF (Cobra venom factor); Ig-like (Immunoglobulin-like protein); GPx (Glutathione peroxidase); LAAO (L-amino acid oxidase); PDE (Phosphodiesterase); KUN (Kunitz-type serine protease inhibitor); PLB (Phospholipase B).
Figure 2The percentage distribution of different protein families in Naja ashei venom proteome calculated on the basis of different research workflows: (a) densitometry after 2DE-MS/MS analysis; (b) Shotgun LC-MS/MS proteomics processed by PeptideShaker; (c) Shotgun LC-MS/MS proteomics processed by MaxQuant; LAP (Low abundant proteins)—proteins whose total percentage share did not exceed 1% were included in the LAP group. The complete list of proteins with its quantitative data is provided in Table S1.
Figure 3The comparison of the number of proteins identified in the upper and the bottom fractions using PeptideShaker (PS) and MaxQuant (MQ) software. In overall, PeptideShaker identified 40 proteins in the upper and 13 proteins in the bottom fraction, while MaxQuant reported 34 hits for the upper and 24 hits for the bottom fraction.
Protein families detected in fractions of Naja ashei venom using PeptideShaker (PS) or MaxQuant (MQ) software. The values in brackets represent the percentage share of a given group in a certain fraction but they are only included if the amount of certain family was not below one-thousandth of a percent. All values are available in Table S1.
| Venom Fraction (Software) | ||||
|---|---|---|---|---|
| Protein Family | Upper Fraction (PS) | Bottom Fraction (PS) | Upper Fraction (MQ) | Bottom Fraction (MQ) |
| 3FTx | +(77.27%) | +(98.28%) | +(93.36%) | +(99.90%) |
| PLA2 | +(14.18%) | +(1.21%) | +(5.47%) | +(0.08%) |
| SVMP | +(1.74%) | - | +(0.20%) | +(0.001%) |
| VNGF | +(2.63%) | +(0.52%) | +(0.54%) | +(0.02%) |
| CRISP | +(1.92%) | - | +(0.32%) | +(0.005%) |
| CVF | +(0.12%) | - | +(0.005%) | +(0.001%) |
| Nucleases | +(0.90%) | - | +(0.03%) | + |
| Ig-like | +(0.37%) | - | +(0.01%) | + |
| GPx | +(0.45%) | - | +(0.04%) | + |
| LAAO | +(0.16%) | - | +(0.02%) | + |
| PDE | +(0.11%) | - | - | - |
| KUN | - | - | +(0.007%) | +(0.01%) |
| PLB | +(0.09%) | - | - | - |
| TF-like | +(0.07%) | - | - | - |
TF-like (Transferrin-like protein).
Figure 4The percentage distribution of different protein families in upper fraction: (a) calculated with PeptideShaker (PS); (b) calculated by MaxQuant (MQ); and bottom fraction: (c) calculated with PeptideShaker; (d) calculated by MaxQuant (MQ). LAP (Low abundant proteins)—proteins whose total percentage share did not exceed 1% were included in the LAP group.
Figure 5Representative gel images of the samples separated with SDS-PAGE under (a) reducing and (b) non-reducing conditions. Electrophoresis was performed on 17% stacking gels. UF (Upper fraction); BF (Bottom fraction); CV (Crude venom); M(Bi) (ROTI®Mark BI-PINK protein mass marker); M(Tri) (ROTI®Mark TRICOLOR mass marker).